Back
Sonnet BioTherapeutics Holdings Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Sell
33
SONN
Sonnet BioTherapeutics Holdings
Last Price:
1.88
Seasonality Move:
-15.89%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SONN is experiencing slight selling pressure.
Sonnet BioTherapeutics Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Buy |
| 20-day SMA: | 1.84 | Buy |
| 50-day SMA: | 1.9 | Sell |
| 200-day SMA: | 2.76 | Sell |
| 8-day EMA: | 1.83 | Buy |
| 20-day EMA: | 1.84 | Buy |
| 50-day EMA: | 1.84 | Buy |
| 200-day EMA: | 5.93 | Sell |
Sonnet BioTherapeutics Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 50.67 | Buy |
| Chaikin Money Flow: | -2718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 1.97) | Buy |
| Bollinger Bands (100): | (1.47 - 1.95) | Buy |
Sonnet BioTherapeutics Holdings Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sonnet BioTherapeutics Holdings Stock
Is Sonnet BioTherapeutics Holdings Stock a Buy?
- Sonnet BioTherapeutics Holdings share price is 1.86 while SONN 8-day simple moving average is 1.82, which is a Buy signal.
- The stock price of SONN is 1.86 while Sonnet BioTherapeutics Holdings 20-day SMA is 1.84, which makes it a Buy.
- Sonnet BioTherapeutics Holdings 50-day simple moving average is 1.90 while SONN share price is 1.86, making it a Sell technically.
- SONN stock price is 1.86 and Sonnet BioTherapeutics Holdings 200-day simple moving average is 2.76, creating a Sell signal.
SONN Technical Analysis vs Fundamental Analysis
Sell
33
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings a Buy or a Sell?
-
Sonnet BioTherapeutics Holdings stock is rated a Sell
The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.86. The Score for SONN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Sonnet BioTherapeutics Holdings Stock Info
Market Cap:
5.71M
Price in USD:
1.86
Share Volume:
7.52K
Sonnet BioTherapeutics Holdings 52-Week Range
52-Week High:
26.40
52-Week Low:
1.08
Sell
33
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Sonnet BioTherapeutics Holdings Share Price Forecast
-
What is the Sonnet BioTherapeutics Holdings stock price today?
The Sonnet BioTherapeutics Holdings stock price is 1.86 USD today. -
Will SONN stock go up or go down?
Sonnet BioTherapeutics Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Sonnet BioTherapeutics Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sonnet BioTherapeutics Holdings is overvalued.
Is Sonnet BioTherapeutics Holdings Stock a Buy?
- Sonnet BioTherapeutics Holdings share price is 1.86 while SONN 8-day exponential moving average is 1.83, which is a Buy signal.
- The stock price of SONN is 1.86 while Sonnet BioTherapeutics Holdings 20-day EMA is 1.84, which makes it a Buy.
- Sonnet BioTherapeutics Holdings 50-day exponential moving average is 1.84 while SONN share price is 1.86, making it a Buy technically.
- SONN stock price is 1.86 and Sonnet BioTherapeutics Holdings 200-day simple moving average is 5.93, creating a Sell signal.
Fundamental Analysis of Sonnet BioTherapeutics Holdings
Is Sonnet BioTherapeutics Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.07 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Sonnet BioTherapeutics Holdings
Should I short Sonnet BioTherapeutics Holdings stock?
- SONN Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Sonnet BioTherapeutics Holdings is a Sell
- Sonnet BioTherapeutics Holdings Relative Strength Index (RSI) is 50.67, which suggest Sonnet BioTherapeutics Holdings is overbought
- The Bollinger Bands (25) for Sonnet BioTherapeutics Holdings is (1.75 - 1.97), which suggest Sonnet BioTherapeutics Holdings is a Buy
- The Bollinger Bands (100) for Sonnet BioTherapeutics Holdings is (1.47 - 1.95), which suggest Sonnet BioTherapeutics Holdings is a Buy
* Sonnet BioTherapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.